Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
MARIJUANA AS MEDICINE: CURRENT UNDERSTANDING AND TRENDS Penelope P. Ziegler, M.D. Medical Director Professionals Resource Network (PRN) Primary Psychoactive IngredientTetrahydrocannabinol THC Mimics Neurotransmitter Anandamide in the Brain’s Endocannabinoid System Cannabis Is a Plant • 484 known biological compounds • Flowers, seeds, leaves and stems are consumed • Smoking • Vaporization • Concentrated oils • Infused “teas” • Edibles, plant usually cooked into foods • At least 84 brain-active cannabinoids • THC • Cannabidiol (CBD) • Cannabinol (CBN) • Many others with unclear or unknown effects Marijuana Has Been Used As Medicine Throughout History • Ancient History • Used in Chinese medicine dating back 10,000 years; still a basic herbal in Traditional Chinese Medicine • Ancient Egypt- hemorrhoids and other inflammatory conditions • India- used for insomnia, pain, digestive problems • Ancient Greece- extensive veterinary uses, also in humans (nosebleeds, tapeworms, etc.) • Middle East- used as antiemetic, diuretic, antiepileptic, anti-inflammatory • Western Medicine • Europe- used for muscle spasms, stomach cramps • America- widespread use in “patent medicines” • Modern times- Advocates Support Use for Many Conditions • Insomnia • Pain • Nausea and vomiting • Decreased appetite with weight loss • Muscle spasms • Epilepsy • Glaucoma What Is the Evidence for Cannabis as a Medication? • Nausea and vomiting in cancer chemotherapy (CINV) • 2010 Cochran review- “probably effective” in children but with high incidence of side effects; inadequate evidence for effectiveness in adults • European meta-analysis of synthetic cannabinoids showed superior antiemetic effects but higher side effects • Additional concern- cannabis induced hyperemesis • Glaucoma- probably not effective in reasonable doses • Wasting syndrome in AIDS- inadequate evidence, studies flawed • Muscle spasms, spasticity- variable results with MS, small studies • Insomnia- small study showed improvement in sleep patterns in fibromyalgia patients • Pain- reviews show some benefits but studies are hard to compare Recent Review of Medical Marijuana in Neurological Disorders Koppel BS, Brust JCM, Fife T et al. 2014 Neurology. 82:1556-1563 • Spasticity • Oral cannabis extract (OCE) effective, nabiximols and THC probably effective for reducing patient-centered measures • OCE and THC possibly effective for both patient-centered and objective measures at 1 year • Central pain, painful spasms • • OCE effective THC and nabiximols probably effective • Urinary dysfunction • • Nabiximols probably effective for reducing voids/day THC and OCE probably ineffective for reducing all bladder complaints • Tremor • • THC and OCE probably ineffective Nabiximols possibly ineffective • Other conditions • • Unknown efficacy in Huntington’s disease, Tourette syndrome, cervical dystonia, epilepsy Probably ineffective in Parkinson disease • High incidence of serious adverse reactions (almost 1%) and side effects What Are Risks, Adverse Effects • Side effects • Addiction • Impaired motor skills • Cognitive impairment • Motivational impairment • Risks associated with method of consumption • Special risks for adolescents • Impact on brain development • Psychotic syndromes • Cyclic vomiting syndrome FDA- Approved Cannabinoids Are Already Available in U.S. • Dronabinol (Marinol®)- Schedule III, approved for CINV, wasting syndrome in AIDS • Nabilone (Cesamet®)- Schedule II, approved for CINV • Nabiximols (Sativex®)- oral mucosal spray, not approved in U.S., used in Canada and Europe. Currently in Phase III trials in US for MS, cancer pain, CINV What Is “Charlotte’s Web” • “Charlotte’s Web” or “Realm Oil” is extracted from a strain of marijuana bred by crossing Cannabis sativa (marijuana) and Cannabis indica (hemp) that has low levels of THC and high levels of CBD (cannabidiol) • Developed by the Stanley brothers, major marijuana growers in Colorado • Named after Charlotte Figi, a seven year old diagnosed with Dravet Syndrome or SMEI, who had intractable seizures until tried on Realm Oil • This strain of cannabis is not associated with a “high” because of its low THC level and, if imported, would be classified as hemp. • Originally called “Hippie’s Disappointment” • The Stanleys plan to move their Realm Oil operations to Uruguay and import the oil to the U.S. as hemp oil • Hemp oil is legal in all 50 states but most lacks the high levels of CBD Recent References • Degenhardt L, Lintzeris N, Campbell G, et al. Experience of adjunctive cannabis • • • • • • use for chronic non-cancer pain: Findings from the Pain and Opioids IN Treatment (POINT) study. Drug Alcohol Depend. 2015;147:144-150. Koppel BS, Brust JC, Fife T, et al. Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology Neurology. 2014;82:1556-1563. Kahan M, Srivastava A, Spithoff S, Bromley L. Prescribing smoked cannabis for chronic noncancer pain: Preliminary recommendations. Can Fam Physician. 2014;60:1083-1090. Borgelt LM1, Franson KL, Nussbaum AM, Wang GS. The pharmacologic and clinical effects of medical cannabis. Pharmacotherapy. 2013;33:195-209. Cooper ZD, Comer SD, Haney M. Comparison of the analgesic effects of dronabinol and smoked marijuana in daily marijuana smokers. Neuropsychopharmacology 2013 38:1984-92. Bostwick M. Blurred boundaries: the therapeutics and politics of medical marijuana. Mayo Clin Proc. February 2012 87(2):172-186. Whiting PF, Wolff RF, Deshpande S, Di Nisio M, Duffy S, Hernandez AV, et al. Cannabinoids for medical use: A systematic review and meta-analysis. JAMA 2015 313(24): 2456-2473.